Market Place
Sourcing Support
Vivani Medical Reveals 2025 Financials And Business Update
26 Mar 2026 //
GLOBENEWSWIRE
Telangana DCA Issues Safety Advisory On Use Of Semaglutide
26 Mar 2026 //
PHARMABIZ
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
Indian Drugmakers Flood Market With Cheap Ozempic, Wegovy Copies
23 Mar 2026 //
ECONOMICTIMES
USV Launches `Usema` To Address India`s Metabolic Health Burden
23 Mar 2026 //
EXPRESSPHARMA
ReflexMD Evaluates Safety Risks Of GLP-1 Claims For Semaglutide
20 Mar 2026 //
GLOBENEWSWIRE
Novo To Track Generic Surge As Semaglutide Goes Off Patent
20 Mar 2026 //
ECONOMICTIMES
Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk
20 Mar 2026 //
ECONOMICTIMES
Natco`s Rs1,290 Semaglutide Slashes Diabetes Drug Prices in India
20 Mar 2026 //
ECONOMICTIMES
Eris Launches Weekly Semaglutide Shot At ?220/Shot
20 Mar 2026 //
EXPRESSPHARMA
FDA Approves Wegovy HD to Maximize Weight Loss
20 Mar 2026 //
PR NEWSWIRE
Zydus & Torrent Pharma Partner To Co-Market Semaglutide Injection
18 Mar 2026 //
ECONOMICTIMES
Semaglutide Boom In India Marks Turning Point For GLP-1 Drugs
18 Mar 2026 //
EXPRESSPHARMA
Ozempic Generics Set To Disrupt India`s Weight-Loss Market
15 Mar 2026 //
ECONOMICTIMES
Mankind Pharma Targets Early Semaglutide Launch
15 Mar 2026 //
ECONOMICTIMES
TIXiMED Reveals Oral TIX100 Prevents Weight Regain Post GLP-1
10 Mar 2026 //
PHARMIWEB
Hoth` HT-VA Restores Cholesterol Levels In MASLD Model
10 Mar 2026 //
PR NEWSWIRE
Veru Enrolls 1st Patient In Trial For Enobosarm & Semaglutide
09 Mar 2026 //
GLOBENEWSWIRE
Direct Meds Releases 2026 Report on Semaglutide, Tirzepatide
09 Mar 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
Ahead Of Its Time, A GLP-1 Drug Almost Made It Out Of India
04 Mar 2026 //
ECONOMICTIMES
Novo Allocates $506M To Convert Irish Plant For Oral Wegovy
02 Mar 2026 //
BIOSPACE
Glenmark Set To Join Peers In `Semaglutide` Push
02 Mar 2026 //
ECONOMICTIMES
Eli Lilly Holds Premium Price Ahead of Generic Rivals
02 Mar 2026 //
ECONOMICTIMES
Viral High-Protein Portions Signal Shift In GLP-1 Supply Chain
28 Feb 2026 //
PRESS RELEASE
Abbott Signs Pact With Novo Nordisk To Offer Semaglutide
28 Feb 2026 //
ECONOMICTIMES
PharmaGiant Expands Access To Affordable Medications
27 Feb 2026 //
PR NEWSWIRE
MSN Labs Expands Metabolic Care In India With CDSCO Approval
27 Feb 2026 //
PHARMABIZ
Zydus Launches Semaglutide in India After Patent Expiry
26 Feb 2026 //
EXPRESSPHARMA
Lilly`s Orforglipron Beats Semaglutide in Type 2 Diabetes Trial
26 Feb 2026 //
PR NEWSWIRE
Lilly Tops Novo In Weight Loss Again, This Time On The Oral Front
26 Feb 2026 //
BIOSPACE
Sprout Health Unveils 2026 GLP-1 Weight Loss Program
25 Feb 2026 //
GLOBENEWSWIRE
Zydus to launch generic semaglutide injections in India
25 Feb 2026 //
ECONOMICTIMES
Semaglutide Patent Expiry Slashes India`s Weight-Loss Drug Prices
25 Feb 2026 //
ECONOMICTIMES
Eris, Natco Pharma Partner For Semaglutide Launch In India
25 Feb 2026 //
INDPHARMAPOST
Novo Plans List Price Reduction For Semaglutide Drugs In `27
24 Feb 2026 //
FIERCE PHARMA
Novo`s CagriSema Trial Deals Blow in Obesity drug Battle Lilly
24 Feb 2026 //
REUTERS
Dr Reddy`s Readies Day-1 Launch Of Semaglutide Generic
18 Feb 2026 //
ECONOMICTIMES
EU Approves Enhanced Wegovy for Obesity in Adults
17 Feb 2026 //
GLOBENEWSWIRE
Compounded Semaglutide For Weight Loss Explained In Hellonation
16 Feb 2026 //
PR NEWSWIRE
NATCO Receives CDSCO Approval For Semaglutide In India
15 Feb 2026 //
INDPHARMAPOST
US May Fine Hims Over Brief Wegovy Copy Launch
13 Feb 2026 //
REUTERS
SFDA Approves OneSource`s Generic Semaglutide in Saudi Arabia
11 Feb 2026 //
EXPRESSPHARMA
Hoth Therapeutics Reports HT-VA GDNF Outperforms Semaglutide
10 Feb 2026 //
PR NEWSWIRE
Meijer Announces New Affordable Access To GLP-1 Medications
10 Feb 2026 //
PR NEWSWIRE
FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad
10 Feb 2026 //
RAPS
Astrazeneca`s Oral GLP-1 Scored Phase 2 Wins, But No Data Yet
10 Feb 2026 //
FIERCE BIOTECH
Novo Nordisk Sues Hims & Hers Over Counterfeit Wegovy®
09 Feb 2026 //
GLOBENEWSWIRE
Hims to stop offering GLP-1 pill after FDA warned of crackdown
09 Feb 2026 //
REUTERS
Novo Nordisk Launches Wegovy® Pill For Consumers At Major Event
06 Feb 2026 //
PR NEWSWIRE
FDA Commissioner Pledges Crackdown On Compounding Practices
06 Feb 2026 //
FIERCE PHARMA
Hims & Hers Launches $49/Month Weight Loss Compound
05 Feb 2026 //
PHARMIWEB
Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill
05 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Addresses Hims & Hers` Illegal Compounding
05 Feb 2026 //
GLOBENEWSWIRE
Publix Pharmacy Provides Savings On Certain GLP-1 Medications
03 Feb 2026 //
BUSINESSWIRE
Skye Reports Positive Cbeyond Ph 2A Extension Interim Study
02 Feb 2026 //
GLOBENEWSWIRE
Novo`s next-gen obesity drug outperforms Wegovy in diabetes trial
02 Feb 2026 //
REUTERS
Novo`s Cagrisema Tops Semaglutide In Ph. 3 Diabetes Study
02 Feb 2026 //
FIERCE BIOTECH
LIR Life Sciences: Positive CPP Transdermal GLP/GIP Data Reported
29 Jan 2026 //
ACCESSWIRE
Sun Pharma Receives DCGI Approval For Generic Semaglutide
23 Jan 2026 //
ECONOMICTIMES
